BARINTHUS BIOTHERAPEUTICS PL (BRNS) Stock Analyst Ratings
USA - NASDAQ:BRNS - US91864C1071 - ADR
1.36 USD
-0.1 (-6.85%)
1.3304 USD
-0.03 (-2.18%)
ChartMill assigns a Buy % Consensus number of 84% to BRNS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.59. This target is 237.5% above the current price.
BRNS was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about BRNS.
In the previous month the buy percentage consensus was at a similar level.
BRNS was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | Alliance Global Partners | Maintains | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-13 | Barclays | Maintains | Overweight |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |